Copyright
©The Author(s) 2020.
World J Gastroenterol. Sep 21, 2020; 26(35): 5328-5342
Published online Sep 21, 2020. doi: 10.3748/wjg.v26.i35.5328
Published online Sep 21, 2020. doi: 10.3748/wjg.v26.i35.5328
Figure 1 Expression of RBBP4 in colon cancer cell lines and its effect on cell proliferation.
A: Protein level of RBBP4 in the colon cancer cell lines quantified by western blotting; B: mRNA level of RBBP4 in the colon cancer cell lines quantified by polymerase chain reaction; C: RBBP4 siRNA efficiency verified by western blotting in SW620 and HCT116 cells; D: Cell viability was detected by the Cell Counting Kit-8 assay in HCT116 cells; E: Cell viability was detected by the Cell Counting Kit-8 assay in SW620 cells; F and G: Cell proliferation was detected by 5-ethynyl-2’-deoxyuridine assay in HCT116 cells and SW620 cells. bP < 0.01 vs controls. EdU: 5-Ethynyl-2’-deoxyuridine.
- Citation: Li YD, Lv Z, Zhu WF. RBBP4 promotes colon cancer malignant progression via regulating Wnt/β-catenin pathway. World J Gastroenterol 2020; 26(35): 5328-5342
- URL: https://www.wjgnet.com/1007-9327/full/v26/i35/5328.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i35.5328